Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels, including conditions like coronary artery disease, heart failure, and stroke. These ailments are a leading cause of global mortality, with risk factors such as hypertension, high cholesterol, smoking, and diabetes contributing to their prevalence. Symptoms may vary but often include chest pain, shortness of breath, and fatigue. Preventive measures involve adopting a heart-healthy lifestyle through regular exercise, a balanced diet, and avoiding tobacco use. Timely medical check-ups and managing risk factors can significantly reduce the likelihood of developing CVD. Treatment options encompass medications, lifestyle modifications, and, in severe cases, surgical interventions like angioplasty or bypass surgery. Awareness campaigns emphasize the importance of early detection and intervention. While progress has been made in reducing CVD-related deaths, the global burden remains substantial. Public health initiatives, education, and research play crucial roles in the ongoing effort to combat cardiovascular diseases and improve overall heart health.
Speaker lineup for this track will be announced soon.
Browse all speakers →Background: Chronic stable angina is the most prevalent symptom of ischemic heart disease and its management is a priority. Trimetazidine and Ranolazine are recommended as add-on drugs to relieve…
Background : As one of the leading causes of death and disability, cardiovascular disease is mostly caused by coronary atherosclerosis. And the gut microbiota probably plays an important role in…
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Oral and poster slots for original Cardiovascular Diseases work, reviewed by the scientific committee.
Meet public health researchers, educators, and policy leaders from around the world across three days.
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Plenary lectures from leading voices shaping Cardiovascular Diseases research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Cardiovascular Diseases track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in Cardiovascular Diseases. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in Cardiovascular Diseases are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IPHC 2027 is a hybrid conference — attend the Cardiovascular Diseases track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
